Mounjaro Injection, Solution
Product Images NDC 50090-8021

Product Visual Gallery

This gallery contains 64 technical images submitted to the FDA as part of the official labeling for Mounjaro (NDC 50090-8021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500908021)

MOUNJARO 10 mg/.5 mL tirzepatide injection, solution vial label from A-S Medication Solutions. The subcutaneous injection product is provided in a 0.5 mL vial, with instructions to store below 86 degrees Fahrenheit and protect from light. The label includes dosage and lot information along with storage and usage precautions.*

FDA Label Image

Figure (Logo)

FDA Label Image

Figure (Moun Pen Ifu 1 V3)

MOUNJARO 10 mg/0.5 mL injection pen for subcutaneous use. The image shows a pre-filled pen injector device, primarily white with a gray tip and a purple end cap, labeled by A-S Medication Solutions.*

FDA Label Image

Figure (Moun Pen Ifu 10 V2)

Illustration showing the gray plunger of a syringe, which is likely part of the MOUNJARO (tirzepatide) injection delivery system. The image focuses on the syringe plunger mechanism relevant to subcutaneous injection preparation or administration.*

FDA Label Image

Figure (Moun Pen Ifu 2 V2)

An instructional diagram illustrating parts of a subcutaneous injection pen device for tirzepatide injection solution. Key labeled components include a purple injection button at the top, a lock ring, an indicator, lock or unlock symbols, the medicine reservoir, a clear base, and a gray base cap at the needle end.*

FDA Label Image

Figure (Moun Pen Ifu 3 V2)

An instructional diagram highlighting the location of the expiration date on a MOUNJARO 10 mg/0.5 mL tirzepatide injection pen. The expiration date is indicated on the pen's body, near the bottom, and is marked with an arrow and label for clear visibility.*

FDA Label Image

Figure (Moun Pen Ifu 4a V1)

An anatomical illustration highlighting common subcutaneous injection sites on a human figure. Purple shaded areas indicate the abdomen around the navel and the front upper thighs, suggesting typical locations for administering injections such as the MOUNJARO tirzepatide solution.*

FDA Label Image

Figure (Moun Pen Ifu 4b V1)

Illustration showing preferred subcutaneous injection sites for MOUNJARO (tirzepatide) on the human body, highlighting the outer upper arms in purple areas as appropriate locations for injection.*

FDA Label Image

Figure (Moun Pen Ifu 5 V2)

An instructional diagram showing how to remove the gray base cap from a MOUNJARO 10 mg/.5 mL injection pen. The illustration highlights the clear base of the pen and the gray base cap, with an arrow indicating the direction to pull off the cap, held by a hand.*

FDA Label Image

Figure (Moun Pen Ifu 6 V2)

An instructional illustration showing the administration of MOUNJARO (tirzepatide) 10 mg/0.5 mL injection solution via a subcutaneous route, depicting a person injecting the medication into the abdominal area.*

FDA Label Image

Figure (Moun Pen Ifu 7 V2)

An instructional illustration showing a hand holding a MOUNJARO (tirzepatide) injection pen. The image highlights a close-up detail of a lock icon on the pen, along with an arrow indicating a twisting or unlocking motion, suggesting an unlocking step before use.*

FDA Label Image

Figure (Moun Pen Ifu 8 V2)

An instructional illustration showing a person holding a MOUNJARO (tirzepatide) injection pen near the abdomen, demonstrating the subcutaneous injection technique. The hand grips the pen with the needle pointed towards the skin, indicating proper administration method for the injectable solution.*

FDA Label Image

Figure (Moun Pen Ifu 9 V2)

An illustration showing the lower part of a syringe-like device intended for subcutaneous injection. The image highlights the gray plunger component inside the clear plastic barrel with a red arrow and label reading "Gray Plunger." This diagram is likely instructional for proper identification or use of the injection device.*

FDA Label Image

Figure (Moun Qr)

FDA Label Image

Structural Formula (Moun Uspi Chem Struc)

Chemical structure diagram of tirzepatide, the active ingredient in MOUNJARO injection solution. The structure shows the peptide sequences and chemical bonds characteristic of this synthetic molecule.*

FDA Label Image

Figure 1 (Moun Uspi F1 V1)

A line graph depicting insulin levels (mIU/L) over time (minutes) comparing placebo and tirzepatide 15 mg at baseline and week 28, showing two phases of insulin response with tirzepatide demonstrating increasing insulin levels over 120 minutes, while placebo levels remain relatively flat.*

FDA Label Image

Figure 2 (Moun Uspi F2 V1)

A line graph comparing the effects of MOUNJARO at 5 mg, 10 mg, and 15 mg doses versus Semaglutide 1 mg on HbA1c (%) levels over a 40-week post-randomization period, showing trends of HbA1c reduction over time for each treatment group.*

FDA Label Image

Figure (Moun Vial Ifu 1 V1)

An anatomical illustration of a MOUNJARO (tirzepatide) injection vial labeling key components: a protective cap on top and a rubber stopper located beneath the cap. The vial is cylindrical with a label that includes the product name and generic name.*

FDA Label Image

Figure (Moun Vial Ifu 10 V1)

An instructional illustration showing two hands preparing a syringe for injection. One hand holds a vial while the other hand is pushing the syringe needle into the vial, indicated by a directional arrow. The image demonstrates the step of drawing medication from a vial before injection.*

FDA Label Image

Figure (Moun Vial Ifu 11 V1)

An instructional illustration showing two hands preparing a subcutaneous injection by drawing solution from a vial into a syringe. The image includes an arrow indicating the plunger being pulled back to draw medication into the syringe.*

FDA Label Image

Figure (Moun Vial Ifu 12 V1)

An instructional illustration demonstrating how to administer a subcutaneous injection using a syringe. The image shows a hand holding the syringe against the skin with an arrow indicating downward injection. A close-up inset of the syringe displays volume markings from 0.0 to 0.5 mL.*

FDA Label Image

Figure (Moun Vial Ifu 13 V1)

An instructional illustration showing two hands preparing a syringe by drawing solution from a vial, demonstrating proper technique for medication administration.*

FDA Label Image

Figure (Moun Vial Ifu 14 V1)

An instructional illustration showing a hand holding an injection pen and another hand drawing medication into a syringe. A close-up shows the syringe barrel with measurement markings from 0.1 to 0.5 mL, emphasizing correct dosage measurement for subcutaneous injection.*

FDA Label Image

Figure (Moun Vial Ifu 15 V1)

An instructional illustration showing a hand holding a vial of medication and another hand holding a syringe with the needle toward the vial, accompanied by an arrow indicating the syringe should be inserted into the vial. This likely depicts how to draw medication from the vial for subcutaneous injection.*

FDA Label Image

Figure (Moun Vial Ifu 16 V1)

Illustration showing recommended subcutaneous injection sites for MOUNJARO (tirzepatide) injection, solution. The sites highlighted include the abdomen and the front of the thighs on a human torso and upper legs outline.*

FDA Label Image

Figure (Moun Vial Ifu 17 V1)

An instructional anatomical illustration showing the back view of a human figure with shaded areas on the upper arms, indicating recommended subcutaneous injection sites for medication administration.*

FDA Label Image

Figure (Moun Vial Ifu 18 V1)

An instructional diagram showing a person administering a subcutaneous injection into the abdominal area. The illustration highlights the positioning of the syringe near the skin, indicating the injection technique for a subcutaneous injection, likely related to the MOUNJARO injection solution.*

FDA Label Image

Figure (Moun Vial Ifu 19 V1)

An instructional illustration showing a person administering a subcutaneous injection into the lower abdominal area. The image depicts the hand holding a syringe at a 90-degree angle to the skin just above the waistband, with an arrow indicating the direction of injection.*

FDA Label Image

Figure (Moun Vial Ifu 2 V1)

Illustration showing a labeled injection syringe with components including the needle shield, needle, syringe body with volume markings, plunger tip, and plunger. An enlarged section highlights the volume measurement near 0.5 mL.*

FDA Label Image

Figure (Moun Vial Ifu 20 V1)

Black and white instructional illustration showing a hand holding a syringe for subcutaneous injection. The syringe is being inserted at an angle into the skin of the abdomen below the waistband, indicated by an arrow pointing towards the injection site.*

FDA Label Image

Figure (Moun Vial Ifu 3 V1)

An instructional illustration showing a hand holding a vial and another hand removing the cap by lifting it upward. The image likely depicts a step in the preparation or administration of a medication injection, relevant to subcutaneous injection products.*

FDA Label Image

Figure (Moun Vial Ifu 4 V1)

An instructional illustration showing two hands removing a cap from a small vial or injection bottle, likely related to the preparation of an injectable medication.*

FDA Label Image

Figure (Moun Vial Ifu 5 V1)

An instructional illustration showing a person preparing a subcutaneous injection by drawing medication from a vial into a syringe. The image depicts hand positioning and syringe usage consistent with injectable medication administration.*

FDA Label Image

Figure (Moun Vial Ifu 6 V1)

An instructional illustration showing a pair of hands holding a small vial or container, with one hand peeling off a label or protective strip. This image appears to demonstrate proper handling or preparation of a medication vial or packaging.*

FDA Label Image

Figure (Moun Vial Ifu 7 V1)

An instructional illustration showing a close-up of a pen-style injection device with a ribbon-like strip partially peeled away or wrapped around it, likely demonstrating a step in the use or preparation of the injection device.*

FDA Label Image

Figure (Moun Vial Ifu 8 V1)

An instructional illustration showing hands holding a syringe for the subcutaneous injection of MOUNJARO (tirzepatide) 10 mg/0.5 mL solution. The image demonstrates pulling or preparing the syringe in the direction of an arrow pointing left.*

FDA Label Image

Figure (Moun Vial Ifu 9 V1)

An instructional illustration showing a hand holding a syringe with a needle, with a downward arrow indicating movement. A close-up inset shows the syringe barrel with measurement markings from 0.1 to 0.5 mL, highlighting the liquid level. No text or branding visible.*

FDA Label Image

Figure (Moun Vial Md Ifu 14 V1)

An instructional illustration showing two hands drawing liquid into a syringe from a vial. The syringe is marked with measurement increments, highlighting the 0.5 mL level, with an arrow pointing upward indicating the drawing up motion.*

FDA Label Image

Figure (Moun Vial Md Ifu 2 V1)

An instructional diagram of a syringe labeled with its parts, including needle shield, needle, syringe body, plunger tip, and plunger. The syringe body displays a volume scale from 0 to 1 milliliter, with a close-up inset highlighting the 0.5 to 0.7 mL markings.*

FDA Label Image

Figure (Moun Vial Md Ifu 9 V1)

An instructional illustration showing a hand holding a syringe with volume markings from 0.1 to 0.6 mL. The syringe is positioned above an injection site indicated by a downward arrow, demonstrating a subcutaneous injection technique.*

FDA Label Image

Figure (Mounjaro Kp 1 Pen V1)

MOUNJARO 10 mg/0.5 mL injection pen device for subcutaneous use, labeled by A-S Medication Solutions. The image shows a white and gray prefilled injection pen with a clear window displaying a dose selector set at '0' and a purple cap at the dose dial end.*

FDA Label Image

Figure (Mounjaro Kp 10 Dial Clicks V1)

Instructional illustration showing a hand peeling back or lifting a rectangular label or seal from a surface, with a red arrow indicating the direction to pull the label upward.*

FDA Label Image

Figure (Mounjaro Kp 11 Dial Zoom V1)

MOUNJARO 10 mg/0.5 mL injection solution in a prefilled pen. The label shows the drug name tirzepatide, dosage strength, and dosage form for subcutaneous use. The labeler is A-S Medication Solutions. The packaging includes dosage instructions and safety warnings in small text.*

FDA Label Image

Figure (Mounjaro Kp 12 Tap V1)

An instructional illustration showing a hand holding a syringe labeled with measurement markings. A finger from the other hand is positioned near the syringe, accompanied by a red arrow pointing left, indicating an action to be performed with the syringe.*

FDA Label Image

Figure (Mounjaro Kp 13 5sec Hold V1)

An instructional illustration showing a hand holding a syringe vertically with an arrow pointing upward, indicating the direction to hold. The inset shows a close-up of the syringe needle with a drop of liquid at the tip. A stopwatch icon is included, suggesting timing is important in the process.*

FDA Label Image

Figure (Mounjaro Kp 14 Zero Dial Zoom V1)

MOUNJARO 10 mg/0.5 mL injection solution label for subcutaneous use. The label shows the proprietary name MOUNJARO with the generic name tirzepatide. It includes product details such as dosage strength and route of administration. The labeler A-S Medication Solutions is displayed along with the product NDC 50090-8021.*

FDA Label Image

Figure (Mounjaro Kp 15 Inj Sites V1)

An instructional diagram showing recommended injection sites for subcutaneous administration. The illustration highlights areas on the abdomen, upper arms, and thighs where injections can be given. The front and back views of a human figure are shown with purple ovals indicating appropriate injection sites.*

FDA Label Image

Figure (Mounjaro Kp 16 Dial 1 Dose V1)

An instructional illustration showing a hand dialing a dose selector on a pen injector device. The image directs users to turn the dial on the pen dose selector, likely part of preparing a subcutaneous injection.*

FDA Label Image

Figure (Mounjaro Kp 17 Dial 1 Zoom V1)

FDA Label Image

Figure (Mounjaro Kp 18 Insert Needle V1)

An instructional illustration showing a hand holding a pen-type injector device, with an arrow pointing toward the upper arm, indicating the site for subcutaneous injection administration.*

FDA Label Image

Figure (Mounjaro Kp 19 Push Hold V1)

An instructional illustration showing a hand holding a subcutaneous injection pen against the thigh. It includes a red arrow labeled 'PUSH' and a stopwatch icon with the instruction to hold for 5 seconds, indicating the injection technique for administering the medication.*

FDA Label Image

Figure (Mounjaro Kp 2 Pen Parts V2)

An instructional diagram showing parts of the MOUNJARO injection pen and needle. The pen components labeled include pen cap with clip, cartridge, plunger, cartridge holder, pen body with label, dose window displaying the dose indicator, and dose knob. Additionally, the pen needle parts are displayed separately, including outer needle shield, inner needle shield, needle, and paper tab, with a note indicating needles are not included. A close-up inset shows a cartridge with a red inner seal.*

FDA Label Image

Figure (Mounjaro Kp 20 Remove V1)

An instructional illustration showing a hand holding a MOUNJARO (tirzepatide) injection pen with the needle inserted subcutaneously into the abdomen area. An arrow points away from the body, indicating the injection direction or action.*

FDA Label Image

Figure (Mounjaro Kp 21 Cotton Ball V1)

An instructional illustration showing the technique for subcutaneous injection in the abdominal area. The image depicts a hand pinching the skin to prepare for injection, with an arrow indicating the injection site.*

FDA Label Image

Figure (Mounjaro Kp 22 Recap Shield V1)

An instructional illustration showing a hand holding an injection pen with the cap being removed by pulling it off in an upward direction, indicated by a red arrow. This likely depicts preparation for subcutaneous injection of the medication.*

FDA Label Image

Figure (Mounjaro Kp 23 Remove Needle V1)

An instructional illustration showing a hand removing a protective cap from the end of an injection pen. A red arrow indicates the direction of cap removal, demonstrating preparation steps for subcutaneous injection administration.*

FDA Label Image

Figure (Mounjaro Kp 24 Recap Pen V1)

An instructional illustration showing a pen-style injection device with its cap partially removed. A red arrow points rightward, indicating the direction to pull or slide the cap off the injection pen prior to use.*

FDA Label Image

Figure (Mounjaro Kp 3 Wash V1)

An instructional illustration showing two hands washing with soap bubbles present, indicating hand hygiene practices.*

FDA Label Image

Figure (Mounjaro Kp 4 Uncap V1)

An illustration showing a close-up of a subcutaneous injection pen with the cap being removed by pulling it off to the left, indicated by a red arrow. The image demonstrates proper handling of an injection device, consistent with the use of MOUNJARO tirzepatide injection.*

FDA Label Image

Figure (Mounjaro Kp 5 Wipe V1)

An instructional illustration showing a hand wiping the top of a medication vial or injection pen with a cloth or swab. A red arrow indicates the motion or direction of wiping, suggesting cleaning or preparing the injection site or device before use.*

FDA Label Image

Figure (Mounjaro Kp 6 New Needle Tab V1)

An instructional illustration showing a hand holding a vial or container, with an arrow indicating a rotational or twisting motion. The image likely depicts a step in the preparation or handling of MOUNJARO (tirzepatide) injection solution for subcutaneous use.*

FDA Label Image

Figure (Mounjaro Kp 7 Attach Needle V1)

An instructional illustration showing how to twist or unlock the cap of a pen injector device by turning the top portion in a clockwise direction, indicated by red arrows. This image is typically used to guide the preparation of a subcutaneous injection device like MOUNJARO (tirzepatide) injection solution.*

FDA Label Image

Figure (Mounjaro Kp 8 Outer Shield V1)

An instructional diagram depicting the removal of a cap from a pen or syringe. The image includes an upward-pointing arrow indicating the direction to pull the cap off the device before use.*

FDA Label Image

Figure (Mounjaro Kp 9 Inner Shield V1)

An instructional illustration showing a syringe with its protective cap being removed by pulling it straight upward. The image includes a red arrow pointing upwards indicating the direction to pull off the needle cap from the injection pen or syringe.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.